Cetera Investment AdvisersCetera Investment Advisers

Institutional investor · Portfolio as of Q2 2020

SEC EDGAR SourceSEC Filings

Top Holdings612 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
VUGVUG
ETF

VANGUARD GROWTH ETF

187,700$37.9M3.5%$22.92+42.09%
7 qtrssince 2018-Q4
Increased
56
QQQQQQ
Unit

INVESCO QQQ TRUST SERIES 1 CL USD INC

124,355$30.8M2.9%$161.51+45.64%
7 qtrssince 2018-Q4
Decreased
0

APPLE INC

73,958$27M2.5%$45.18+95.26%
7 qtrssince 2018-Q4
Increased
54
VTVVTV
ETF

VANGUARD VALUE ETF

199,584$19.9M1.8%$84.91+1.45%
7 qtrssince 2018-Q4
Increased
56

AMAZON.COM INC

6,047$16.7M1.5%$82.92+61.62%
7 qtrssince 2018-Q4
Increased
47

MICROSOFT CORP

77,453$15.8M1.5%$110.10+72.08%
7 qtrssince 2018-Q4
Increased
49
FVDFVD
ETF

FIRST TR EXCHANGE-TRADED FD

518,857$15.7M1.5%$26.65-0.53%
7 qtrssince 2018-Q4
Decreased
0
AGGAGG
ETF

ISHARES TR

126,870$15M1.4%$90.07+9.27%
7 qtrssince 2018-Q4
Increased
56
IJRIJR
ETF

ISHARES CORE S&P SMALL-CAP ETF ETF

217,453$14.9M1.4%$62.17-0.59%
7 qtrssince 2018-Q4
Increased
47
SDYSDY
ETF

SPDR S&P DIVIDEND ETF ETF

161,511$14.7M1.4%$76.06+2.62%
7 qtrssince 2018-Q4
Decreased
0
SPYSPY
Unit

STATE STREET SPDR S&P 500 ETF TRUST CL USD INC

47,651$14.7M1.4%$233.20+20.87%
7 qtrssince 2018-Q4
Decreased
0
VOOVOO
ETF

VANGUARD S&P 500 ETF

46,986$13.3M1.2%$243.54+6.02%
7 qtrssince 2018-Q4
Increased
46
IWFIWF
ETF

ISHARES TR RUSSELL 1000 GROWTH INDEX FUND

64,252$12.3M1.1%$31.08+48.97%
7 qtrssince 2018-Q4
Decreased
0
USMVUSMV
ETF

ISHARES EDGE MSCI MIN VOL US

196,506$11.9M1.1%$53.88+1.53%
7 qtrssince 2018-Q4
Increased
49
IWRIWR
ETF

ISHARES RUSSELL MIDCAP INDEX FUND

211,204$11.3M1.0%$45.66+7.33%
7 qtrssince 2018-Q4
Increased
57
MGKMGK
ETF

VANGUARD MEGA CAP GROWTH ETF

67,016$11M1.0%$28.10+12.83%
4 qtrssince 2019-Q3
Increased
47
GDXGDX
ETF

VANECK GOLD MINERS ETF

270,950$9.9M0.9%$20.76+59.04%
7 qtrssince 2018-Q4
Increased
39
VXUSVXUS
ETF

VANGUARD TOTAL INTL STOCK

200,577$9.9M0.9%$39.50+4.41%
7 qtrssince 2018-Q4
Increased
49
IWDIWD
ETF

ISHARES TR RUSSELL 1000 VALUE INDEX FUND

85,618$9.6M0.9%$95.27+4.99%
7 qtrssince 2018-Q4
Decreased
0
LQDLQD
ETF

ISHARES IBOXX INVESTMENT GRA

71,673$9.6M0.9%$103.36+4.25%
7 qtrssince 2018-Q4
Increased
63
$1.1B
AUM
612
Positions
Q2 2020
Filing
Rating · 4.0
Quarterly Portfolio Change
+16%Q1'19$708.2M+10%Q2'19$775.6M+6%Q3'19$822.9M+21%Q4'19$995.5M-18%Q1'20$816.8M+32%Q2'20$1.1B
Activity profile
$ moved · Q2'20
New13%Increased62%Decreased22%Exited2%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.1 years
<1Q11%1-4Q17%1-2Y72%2Y+0%

Cetera Investment Advisers manages $1.1B across 612 positions as of Q2 2020. Top holdings: VUG (3.5%), QQQ (2.9%), AAPL (2.5%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 4/5.0.

Q2 2020 Summary

Active quarter - 101 new positions, 31 exits, 301 increased. Top move: LQD (INCREASED, conviction 63). Portfolio: $1.1B across 612 positions.

Top holdings by portfolio weight

Total AUM$1B
VUG3.51%
QQQ2.85%
AAPL2.50%
VTV1.84%
AMZN1.55%
MSFT1.46%
FVD1.46%
AGG1.39%
IJR1.38%
SDY1.36%
Other1.36%

Portfolio allocation by GICS sector

Sectors11
Unknown69.04%
Technology7.88%
Financial Services3.55%
Consumer Cyclical3.50%
Healthcare3.28%
Communication Services3.24%
Industrials2.84%
Consumer Defensive2.64%
Utilities1.49%
Energy1.29%
Other1.27%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Unknown
Compare DNA across all funds
7-dimension quality assessment
Strong(4.0 / 5.0)
Track Record58
Conviction42
Concentration25
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
8Q
ABBVABBVABBVIE INC
Q3 2024 Q2 2026+380,469 shares+$144.6M
8Q
LNTLNTALLIANT ENERGY CORP
Q3 2024 Q2 2026+54,323 shares+$7.9M
8Q
ALNYALNYALNYLAM PHARMACEUTICALS INC
Q3 2024 Q2 2026+20,457 shares+$6.3M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used